DST funded company develops membrane oxygenator equipment to treat COVID-19 patients

Question:Membrane oxygenator equipment used to treat breathlessness is developed by which of the following company?
(a) Genrich Membranes
(b) Seagull BioSolutions
(c) Zydus
(d) Ranbaxy
Answer:(a)
Related facts:

  • A Pune based company Genrich Membranes funded by Department of Science and Technology (DST) has developed a membrane oxygenator equipment to treat COVID-19 patients.
  • The device is slated to be used to treat breathlessness, one of the critical symptoms of COVID-19.

Advantage of Instrument:

  • This equipment can also be used to treat patients who have been discharged from Intensive Care Units (ICU).
  • The device enriches oxygen in the air up to 35 per cent and does not require trained manpower for its operation.
  • The innovation promises to be of excellent value as maximum number of patients facing critical breathing illness from diseases including COVID-19 needs such kind of support.

By-Achyutanand Pandey

Links:
http://www.newsonair.com/News?title=DST-funded-company-develops-%26%2339%3Bmembrane-oxygenator-equipment%26%2339%3B-to-treat-COVID-19-patients&id=385123
http://www.newsonair.com/News?title=DST-funded-company-develops-%26%2339%3Bmembrane-oxygenator-equipment%26%2339%3B-to-treat-COVID-19-patients&id=385123